This company is no longer active
The company may no longer be operating, as it may be out of business. Find out why through their latest events.
Resumen de acción EYES
Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
Competidores de Second Sight Medical Products, Inc.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$4.14 |
| 52 Week High | US$12.72 |
| 52 Week Low | US$3.42 |
| Beta | 2.56 |
| 1 Month Change | -23.33% |
| 3 Month Change | -39.74% |
| 1 Year Change | -64.25% |
| 3 Year Change | -77.89% |
| 5 Year Change | -84.46% |
| Change since IPO | -99.14% |
Noticias y actualizaciones recientes
Second Sight, Nano Precision complete merger, renaming as Vivani Medical
Aug 30Second Sight Medical sheds ~17% after reverse stock split
Aug 19Second Sight stock rises as shareholders approve merger, name change, reverse stock split
Jul 29Second Sight stock rises ~10% on $1.1M funding from NIH for artificial vision implant trial
Jul 18Recent updates
Second Sight, Nano Precision complete merger, renaming as Vivani Medical
Aug 30Second Sight Medical sheds ~17% after reverse stock split
Aug 19Second Sight stock rises as shareholders approve merger, name change, reverse stock split
Jul 29Second Sight stock rises ~10% on $1.1M funding from NIH for artificial vision implant trial
Jul 18Revisiting Second Sight Medical Products: The EV Is Negative And Being Short No Longer Looks Appealing
Mar 22Second Sight Medical rises defying legal battle; regains NASDAQ compliance
Jun 04Rentabilidad de los accionistas
| EYES | US Medical Equipment | Mercado US | |
|---|---|---|---|
| 7D | 0.7% | -0.2% | 0.6% |
| 1Y | -64.2% | -1.1% | 23.9% |
Rentabilidad vs. Industria: EYES underperformed the US Medical Equipment industry which returned -28.4% over the past year.
Rentabilidad vs. Mercado: EYES underperformed the US Market which returned -16.7% over the past year.
Volatilidad de los precios
| EYES volatility | |
|---|---|
| EYES Average Weekly Movement | 11.3% |
| Medical Equipment Industry Average Movement | 7.6% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: EYES's share price has been volatile over the past 3 months.
Volatilidad a lo largo del tiempo: EYES's weekly volatility (11%) has been stable over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1998 | 15 | Scott Dunbar | www.secondsight.com |
Resumen de fundamentos de Second Sight Medical Products, Inc.
| Estadísticas fundamentales de EYES | |
|---|---|
| Capitalización bursátil | US$54.38m |
| Beneficios(TTM) | -US$9.07m |
| Ingresos (TTM) | n/a |
0.0x
Ratio precio-ventas (PS)-6.0x
Ratio precio-beneficio (PE)¿Está EYES sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de EYES | |
|---|---|
| Ingresos | US$0 |
| Coste de los ingresos | -US$130.00k |
| Beneficio bruto | US$130.00k |
| Otros gastos | US$9.20m |
| Beneficios | -US$9.07m |
Últimos beneficios comunicados
Jun 30, 2022
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -0.69 |
| Margen bruto | 0.00% |
| Margen de beneficio neto | 0.00% |
| Ratio deuda/patrimonio | 0% |
¿Cómo se ha desempeñado EYES a largo plazo?
Ver rendimiento histórico y comparativa